We are live on
!
Find out more
DAM
DLD Asset Management Portfolio holdings
AUM
$1.51B
Turnover
51.11%
1-Year Est. Return
5.32%
This Fund
S&P 500
This Quarter
Est. Return
+0.96%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$623M
AUM Growth
+$318M
(+104%)
Cap. Flow
-$181M
Cap. Flow
% of AUM
-29%
Top 10 Holdings %
Top 10 Hldgs %
75.39%
Holding
112
New
40
Increased
17
Reduced
5
Closed
34
Avg Time Held Equity + Options
0.1
years
Top 10 Avg Time Held Equity + Options
0.1
years
Top 20 Avg Time Held Equity + Options
0.1
years
Avg Time Held Equity only
0.1
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
|
+$3.75M |
| 2 |
Micron Technology
MU
|
+$3.59M |
| 3 |
ACOR
Acorda Therapeutics
ACOR
|
+$3.51M |
| 4 |
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
|
+$749K |
| 5 |
CWEI
Clayton Williams Energy, Inc.
CWEI
|
+$536K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$2.85M |
| 2 |
AEPI
AEP Industries Inc
AEPI
|
+$1.16M |
| 3 |
STJ
St Jude Medical
STJ
|
+$962K |
| 4 |
RAD
Rite Aid Corporation
RAD
|
+$958K |
| 5 |
YDKN
Yadkin Financial Corporation
YDKN
|
+$685K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 95.54% |
| 2 | Healthcare | 1.83% |
| 3 | Technology | 0.9% |
| 4 | Consumer Staples | 0.44% |
| 5 | Financials | 0.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
PRTK
1
PUT
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $20M | 3.2% |
1,035,800
+989,800
| +2,152% | +$15.6M |
2016 Q4
1 quarter
|
|
2
CALL
NXP Semiconductors
NXPI
$57.4B
| $18.5M | 2.96% |
+178,400
| New | +$18M |
2017 Q1
0 quarters
|
|
3
CALL
DELISTED
Sage Therapeutics
SAGE
| $17.5M | 2.8% |
+245,800
| New | +$14.4M |
2017 Q1
0 quarters
|
|
|
4
PUT
DELISTED
Sage Therapeutics
SAGE
| $15.7M | 2.51% |
+220,300
| New | +$12.9M |
2017 Q1
0 quarters
|
|
5
PUT
ANI Pharmaceuticals
ANIP
$1.66B
| $8.71M | 1.4% |
176,000
+135,000
| +329% | +$7.58M |
2016 Q4
1 quarter
|
|
|
SIOX
6
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $7.86M | 1.26% |
+65,838
| New | +$6.9M |
2017 Q1
0 quarters
|
|
|
SWC
7
PUT
DELISTED
Stillwater Mining Co
SWC
| $7.01M | 1.13% |
+406,000
| New | +$6.94M |
2017 Q1
0 quarters
|
|
|
ZGNX
8
CALL
DELISTED
Zogenix, Inc.
ZGNX
| $5.98M | 0.96% |
552,300
+447,900
| +429% | +$4.54M |
2016 Q4
1 quarter
|
|
|
ACOR
9
DELISTED
Acorda Therapeutics
ACOR
| $5.92M | 0.95% |
2,349
+1,220
| +108% | +$3.51M |
2016 Q4
1 quarter
|
|
|
ACOR
10
PUT
DELISTED
Acorda Therapeutics
ACOR
| $5.91M | 0.95% |
2,349
+288
| +14% | +$829K |
2016 Q4
1 quarter
|
|
11
PUT
Insmed
INSM
$21.4B
| $5.78M | 0.93% |
+330,400
| New | +$5.1M |
2017 Q1
0 quarters
|
|
|
PRTK
12
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $4.78M | 0.77% |
248,406
+238,116
| +2,314% | +$3.75M |
2016 Q4
1 quarter
|
|
13
CALL
DBV Technologies S.A. American Depositary Shares
DBVT
$568M
| $4.44M | 0.71% |
+12,610
| New | +$4.43M |
2017 Q1
0 quarters
|
|
|
14
Micron Technology
MU
$1.03T
| $4.25M | 0.68% |
+147,100
| New | +$3.59M |
2017 Q1
0 quarters
|
|
15
PUT
DELISTED
DigitalBridge
DBRG
| $2.98M | 0.48% |
+57,750
| New | +$3.25M |
2017 Q1
0 quarters
|
|
|
ZYNE
16
PUT
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $2.98M | 0.48% |
+148,400
| New | +$2.95M |
2017 Q1
0 quarters
|
|
|
FOMX
17
CALL
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $2.6M | 0.42% |
+523,900
| New | +$5.04M |
2017 Q1
0 quarters
|
|
|
ARAV
18
CALL
DELISTED
Aravive, Inc. Common Stock
ARAV
| $2.33M | 0.37% |
+18,233
| New | +$1.92M |
2017 Q1
0 quarters
|
|
|
ZYNE
19
CALL
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $2.06M | 0.33% |
+102,400
| New | +$2.03M |
2017 Q1
0 quarters
|
|
|
PRTK
20
CALL
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $1.27M | 0.2% |
+66,100
| New | +$1.04M |
2017 Q1
0 quarters
|
|
|
RAI
21
DELISTED
Reynolds American Inc
RAI
| $1.07M | 0.17% |
17,000
+2,000
| +13% | +$120K |
2016 Q4
1 quarter
|
|
|
BEAV
22
DELISTED
B/E Aerospace Inc
BEAV
| $898K | 0.14% |
14,000
+4,000
| +40% | +$251K |
2016 Q4
1 quarter
|
|
23
CALL
Rocket Pharmaceuticals
RCKT
$255M
| $870K | 0.14% |
109,875
+23,075
| +27% | +$155K |
2016 Q4
1 quarter
|
|
|
IMDZ
24
CALL
DELISTED
Immune Design Corp.
IMDZ
| $814K | 0.13% |
120,100
+99,200
| +475% | +$574K |
2016 Q4
1 quarter
|
|
|
IMMU
25
CALL
DELISTED
Immunomedics Inc
IMMU
| $692K | 0.11% |
+107,200
| New | +$543K |
2017 Q1
0 quarters
|
|
Similar funds
FFM
AWA
SC
HCM
NB
WFA
RIM
AU
DLD Asset Management's Q1 2017 Portfolio in Review
As of Q1 2017, DLD Asset Management held 112 positions worth $623M, up 104% from $305M the previous quarter. Its ten largest holdings account for 75% of the portfolio.
DLD Asset Management withdrew a net $181M in Q1 2017, closing 34 positions and reducing 5 holdings. Its most notable exit was Charter Communications, an estimated $2.85M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 96% of assets, up from 93% a quarter earlier, followed by Healthcare and Technology.
Against the trend, DLD Asset Management opened a new position in Micron Technology worth $4.25M.
- DLD Asset Management's largest Q1 2017 buy was Micron Technology: 147,100 shares worth $4.25M.
- DLD Asset Management added most to Paratek Pharmaceuticals, Inc. in Q1 2017, an estimated $3.75M increase.
- DLD Asset Management's biggest Q1 2017 reduction was PrivateBancorp Inc, cutting an estimated $168K.
- DLD Asset Management fully exited Charter Communications in Q1 2017, selling an estimated $2.85M.
- DLD Asset Management's ten largest holdings make up 75% of its $623M portfolio in Q1 2017.
- DLD Asset Management opened 40 new positions and closed 34 in Q1 2017.
- DLD Asset Management's portfolio value rose 104% quarter-over-quarter to $623M.
Based on DLD Asset Management's 13F filing for Q1 2017, filed 12 May 2017.